United States Self Monitoring Blood Glucose Market

United States Self Monitoring Blood Glucose Market Overview:

The United States self monitoring blood glucose market size reached USD 2.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.5 Billion by 2033, exhibiting a growth rate (CAGR) of 6.2% during 2025-2033. The escalating demand for self monitoring blood glucose equipment including glucose meters, test strips, and lancets to monitor and manage blood glucose levels, along with the rising aging population in the country that requires home-based healthcare options to manage their ailments, is fueling the market growth.

United States Self Monitoring Blood Glucose Market Trends:

Rising Prevalence of Diabetes

According to the IMARC Group’s report, the United States diabetes market size reached US$ 29.3 Billion in 2023. As the number of people diagnosed with diabetes, particularly type 2, is rising, the demand for self monitoring blood glucose (SMBG) equipment including glucose meters, test strips, and lancets is increasing. These gadgets are used to frequently monitor and manage blood glucose levels, which is critical for avoiding complications and properly managing the disease. With an increasing diabetic population, there is a greater emphasis on disease care to avoid serious complications like cardiovascular disease, kidney failure, and neuropathy. Regular blood glucose monitoring is an essential component of diabetes management, necessitating the need for dependable and easily available SMBG systems. Healthcare practitioners are prescribing SMBG as part of a comprehensive diabetes management strategy. As more people are diagnosed with diabetes, physicians are prescribing SMBG devices to assist them control their blood glucose levels within a certain range, which is impelling the market growth. The rising prevalence of pre-diabetes, a condition in which blood sugar levels are higher than usual but not yet high enough to be diagnosed as diabetes, is also bolstering the market growth.

Aging Population Growth

Elderly people, particularly those over the age of 65, are more prone to acquire type 2 diabetes due to variables, such as decreased physical activity, increasing body fat, and insulin resistance. As the population of older people are expanding, the number of people who need SMBG devices to control their diabetes is rising. Older persons are more likely to have many chronic diseases, including diabetes. To avoid difficulties, it is necessary to monitor blood glucose levels on a regular basis. As the population is aging, the demand for SMBG devices as part of chronic disease management is growing. The elderly people often choose or require home-based healthcare options to manage their ailments. SMBG devices enable older people to effortlessly monitor their blood glucose levels at home, decreasing the need for frequent visits to medical institutions. This shift towards home healthcare is propelling the use of SMBG devices among older persons. Diabetes-related consequences in older persons include cardiovascular disease, renal difficulties, and neuropathy. Regular blood glucose monitoring is critical for addressing these risks, resulting in increased demand for SMBG devices in the country. As per the Population Reference Bureau (PRB) website, the number of people aged 65 and older is projected to increase by 82 million by 2050.

United States Self Monitoring Blood Glucose Market News:

• May 2023: LifeScan, a global leader in blood glucose monitoring, revealed about the findings of a study of real-world evidence demonstrating people with type 2 diabetes achieve Sustained Improvements in Readings In-Range Using an Advanced Bluetooth® Connected Blood Glucose Meter and a Mobile Diabetes App, Diabetes Therapy, a peer-reviewed publication, provided real-world evidence from over 55,000 people with diabetes.
• August 2023: The US Food and Drug Administration (FDA) granted clearance for Roche's Accu-Chek Solo micropump system, a tubing-free "patch" pump for people with diabetes who use insulin. The system also offers blood glucose monitoring and bolus advice to users.

United States Self Monitoring Blood Glucose Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on component.

Component Insights:

• Glucometer Devices
• Test Strips
• Lancets
   

The report has provided a detailed breakup and analysis of the market based on the component. This includes glucometer devices, test strips, and lancets.

Regional Insights: 

• Northeast
• Midwest
• South
• West
   

The report has also provided a comprehensive analysis of all the major regional markets, which include Northeast, Midwest, South, and West.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

United States Self Monitoring Blood Glucose Market Report Coverage:

Key Questions Answered in This Report:

• How has the United States self monitoring blood glucose market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the United States self monitoring blood glucose market?
• What is the breakup of the United States self monitoring blood glucose market on the basis of component?
• What are the various stages in the value chain of the United States self monitoring blood glucose market? 
• What are the key driving factors and challenges in the United States self monitoring blood glucose?
• What is the structure of the United States self monitoring blood glucose market and who are the key players?
• What is the degree of competition in the United States self monitoring blood glucose market? 

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the United States self monitoring blood glucose market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the United States self monitoring blood glucose market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the United States self monitoring blood glucose industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.